Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

105.11
Delayed Data
As of May 25
 +1.41 / +1.36%
Today’s Change
92.98
Today|||52-Week Range
140.72
-12.23%
Year-to-Date
Better Buy: Juno Therapeutics vs. bluebird bio
May 25 / MotleyFool.com - Paid Partner Content
How George Soros Invests in Biotech
May 18 / MotleyFool.com - Paid Partner Content
Adding to a Quintet of Longs
May 25 / TheStreet.com - Paid Partner Content
Agios Strikes Metabolic Immuno-Oncology Deal with Celgene
May 18 / Zacks.com - Paid Partner Content
The Single Best Stock to Own Today
May 24 / MotleyFool.com - Paid Partner Content
5 Top Biotech Stocks to Buy on Sale
May 17 / MotleyFool.com - Paid Partner Content
Today's Trades
May 24 / TheStreet.com - Paid Partner Content
5 Stocks We're Never Selling
May 14 / MotleyFool.com - Paid Partner Content
Is Biotech About to Go from Goat to Hero?
May 24 / TheStreet.com - Paid Partner Content
5 Surprising Comments in Merck's Quarterly Conference Call
May 13 / MotleyFool.com - Paid Partner Content
Pfizer's Buyout of Anacor Pharmaceuticals for $5.2 Billion Is a Bad Move -- Here's Wh...
May 24 / MotleyFool.com - Paid Partner Content
bluebird bio Inc: Catnapping in Cambridge
May 12 / MotleyFool.com - Paid Partner Content
The Best Buys in Biopharma Today
May 24 / MotleyFool.com - Paid Partner Content
Bristol-Myers/AbbVie Empliciti Gets Approved in the EU
May 12 / Zacks.com - Paid Partner Content